SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain as well as the Onyx Goliath Blockchain. XCN is also used as an ERC-20 token for Staking and Governance.

Onyxcoin

Onyxcoin is seeing increased volatility and social media buzz as the community anticipates the upcoming launch of the Goliath mainnet. Investors remain divided, with some actively accumulating ahead of the release while others warn of potential sell-the-news price action and past patterns of market manipulation.

Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology therapeutics. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. The company was founded in 2013 and is headquartered in Salt Lake City, UT.

Clene Inc

Clene Inc. is trending as investors aggressively position themselves ahead of a pivotal regulatory milestone, with the community closely tracking the expected submission of an NDA for accelerated approval in ALS. Enthusiastic sentiment is fueled by anticipation of upcoming clinical biomarker data and the potential for a significant re-rating, though some investors remain cautious about the company's cash runway and the history of volatility surrounding speculative biotech catalysts.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. The firm provides online news services where users can select and rank web content. It also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddit is trending as investors debate the impact of broader market volatility and geopolitical tensions on the stock's recent price compression, with the community sharply divided between those calling for a bottom-fishing opportunity based on strong margins and those fearing further downside. Discussion is heavily focused on potential squeeze setups, option positioning, and the stock's tendency to detach from broader software market recoveries.

Bittensor is an open-source protocol that powers a decentralized, blockchain-based machine learning network. Machine learning models train collaboratively and are rewarded in TAO according to the informational value they offer the collective. TAO also grants external access, allowing users to extract information from the network while tuning its activities to their needs.  Ultimately, BitTensors vision is to create a pure market for artificial intelligence, an incentivized arena in which consumers and producers of this valuable commodity can interact in a trustless, open and transparent context.  Bittensor enables:  -A novel, optimized strategy for the development and distribution of artificial intelligence technology by leveraging the possibilities of a distributed ledger. Specifically, its facilitation of open access/ownership, decentralized governance, and the ability to harness globally-distributed resources of computing power and innovation within an incentivized framework.  -An open-source repository of machine intelligence, accessible to anyone, anywhere, thus creating the conditions for open and permission-less innovation on a global internet scale.  -Distribution of rewards and network ownership to users in direct proportion to the value they have added.

Bittensor

Bittensor ($TAO) is capturing intense market attention as traders bet on its decentralized AI infrastructure, driven by anticipation for its upcoming December halving and institutional interest following a Grayscale ETF filing. The community is heavily engaged in discussions around 'subnet' performance and long-term scarcity, frequently comparing the asset's trajectory to Bitcoin's early development cycle.

Fartcoin is a meme-driven cryptocurrency where users can submit their best fart jokes or memes to earn initial tokens. Each transaction triggers a hilarious 'Gas Fee' effect, complete with a digital fart sound for maximum comedic impact.

Fartcoin

$FARTCOIN is capturing significant community attention as traders debate its long-term viability and volatility against a backdrop of broader Solana ecosystem activity. While some market participants view it as a speculative play prone to rapid price swings, others remain engaged in high-volume discussions about its potential as a memecoin bellwether and its recurring support levels.

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

Greenwich LifeSciences Inc

Greenwich LifeSciences is seeing significant investor interest driven by a strategic FDA manufacturing approval and a strong cash position that secures trial funding, while the community anticipates that the upcoming co-authored abstract with a top-tier Steering Committee signals significant clinical progress. Investors are closely monitoring potential buyout or partnership activity as a catalyst for a valuation re-rating, noting a tight float and consistent insider buying as key indicators of long-term confidence.

Vanguard Index Funds - Vanguard Total Stock Market ETF

Vanguard Total Stock Market ETF

The Vanguard Total Stock Market ETF (VTI) remains a central focus for retail investors seeking stability through broad-market exposure amid heightened geopolitical volatility surrounding U.S.-Iran tensions and shifting trade policy. The community is actively debating the merits of long-term passive accumulation versus active risk management as participants navigate potential stagflation risks and the broader economic impacts of current fiscal initiatives.

Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellia Therapeutics is trending after the FDA lifted a clinical hold on its MAGNITUDE-2 trial, fueling bullish sentiment and expectations of a short squeeze among investors. However, community discussions also highlight caution due to a recently expanded shelf offering and the ongoing hold on its larger ATTR-CM study, which some believe caps upside potential in the gene-editing space.

Draganfly, Inc. engages in the manufacture and sale of commercial unmanned aerial vehicle systems and software serving the public safety, agriculture, industrial inspections, security, mapping, and surveying markets. Its products include quad-copters, fixed wing aircrafts, ground based robots, hand held controllers, and software used for tracking, live streaming, and data collection. The firm also offers custom engineering, training, simulation consulting, as well as data and flight training services. The company was founded by Zenon Dragan and Christine Dragan in 1998 and is headquartered in Saskatoon, Canada.

Draganfly Inc

Draganfly Inc. is gaining investor attention following a successful field demonstration of its Outrider drone at the U.S.-Mexico border, which has sparked increased procurement interest from law enforcement and defense agencies. Community discussion is currently split between optimism regarding the company's military-grade technological capabilities and frustration over recent stock price volatility and lingering questions about the timing of major contract awards.

First Solar, Inc. is a solar technology company, which engages in the provision of solar modules. It is involved in the design, manufacture, and sale of cadmium tellurid (CdTe) solar modules, which convert sunlight into electricity. The company was founded by Michael J. Ahearn in 1999 and is headquartered in Phoenix, AZ.

First Solar Inc

First Solar is attracting significant attention as investors weigh the stock's strong utility-scale backlog and role in powering AI data centers against volatility surrounding potential tariff rulings and competitive concerns from Tesla. The community remains divided, with some betting on a long-term breakout driven by energy independence needs, while others are cautious of regulatory headwinds and bearish analyst downgrades.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Mid Cap Stocks To Follow Now - February 18th

ProShares UltraPro Short QQQ, Ondas, Avadel Pharmaceuticals, Direxion Daily TSLA Bull 2X Shares, and American Airlines Group are the five Mid Cap stocks to watch today, according to MarketBeat's...

Best Pharmaceutical Stocks To Watch Today - February 18th

Eli Lilly and Company, Avadel Pharmaceuticals, AbbVie, Novo Nordisk A/S, Pfizer, AstraZeneca, and Vertex Pharmaceuticals are the seven Pharmaceutical stocks to watch today, according to MarketBeat's...

Top Medical Stocks To Follow Now - February 18th

Eli Lilly and Company, UnitedHealth Group, Johnson & Johnson, Avadel Pharmaceuticals, AbbVie, Thermo Fisher Scientific, and Medtronic are the seven Medical stocks to watch today, according to...

Top Mid Cap Stocks To Consider - February 17th

ProShares UltraPro Short QQQ, Masimo, Direxion Daily TSLA Bull 2X Shares, ZIM Integrated Shipping Services, Avadel Pharmaceuticals, Ondas, and Applied Digital are the seven Mid Cap stocks to watch...

Best Pharmaceutical Stocks To Follow Now - February 17th

Eli Lilly and Company, Avadel Pharmaceuticals, and AbbVie are the three Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical stocks are shares of...

Best Pharmaceutical Stocks To Follow Today - February 13th

Eli Lilly and Company, AbbVie, Avadel Pharmaceuticals, Vertex Pharmaceuticals, Rapt Therapeutics, Pfizer, and Gilead Sciences are the seven Pharmaceutical stocks to watch today, according to...

Avadel Pharmaceuticals PLC. (NASDAQ:AVDL) Short Interest Down 36.0% in January

Avadel Pharmaceuticals PLC. (NASDAQ:AVDL - Get Free Report) was the target of a large decline in short interest in the month of January. As of January 30th, there was short interest totaling...

Top Mid Cap Stocks To Watch Now - February 12th

ProShares UltraPro Short QQQ, Icon, Fastly, Direxion Daily TSLA Bull 2X Shares, Avadel Pharmaceuticals, American Airlines Group, and Cognex are the seven Mid Cap stocks to watch today, according to...

Pharmaceutical Stocks To Watch Today - February 12th

Eli Lilly and Company, Avadel Pharmaceuticals, AbbVie, Gilead Sciences, and Pfizer are the five Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical...

Alkermes plc Completes Acquisition of Avadel Pharmaceuticals plc, Accelerating Entry Into Sleep Medicine Market

Alkermes plc (Nasdaq: ALKS) (Alkermes) and Avadel Pharmaceuticals plc (Nasdaq: AVDL) (Avadel) today announced Alkermes completion of its acquisition of Avadel, a commercial-stage biopharmaceutical...

Avadel Pharmaceuticals Plc engages in the development and commercialization of pharmaceutical products. Its main product is LUMRYZ is an extended-release formulation of sodium oxybate, which used in the treatment of cataplexy or EDS in adults with narcolepsy. The company was founded on July 21, 1990 and is headquartered in Dublin, Ireland.

Current Price	$21.64
Prev Close	$21.63
Open	$21.66
Dividend Yield	0.00%
50-Day Moving Average	$21.58
Beta	0.70
Avg. Volume	2.43M
PE Ratio	-3,934.55

52-Week High	$23.57
52-Week Low	$6.38
Market Capitalization	$2.11B
EPS (Annual)	-$0.5133
Price to Book	21.42
Revenue Per Employee	$899,558.51

AVDL
Avadel Pharm Sp ADR

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest AVDL News

AVDLAvadel Pharm Sp ADR